White matter lesions (WML) associated with cerebrovascular disease (CVD) may be observed on magnetic resonance imaging in Parkinson's disease (PD) patients. WML are an important factor contributing to postural, gait, and cognitive impairment in the elderly without PD and worsening the course of Alzheimer's disease (AD). Numerous articles are available on this topic. Whether WML modify and negatively influence the clinical symptoms, and course of PD is a subject of debate. The aim of this review is to examine the available literature on the contribution of WML to PD motor symptoms in relation to clinical characteristics and methods of assessing WML on MRI. After reviewing the database, we identified 19 studies reporting the relationship between WML and PD; ten studies focusing on the impact of WML on the cognitive status in PD were excluded. We analysed altogether nine studies reporting the relationship between WML and motor signs of PD. The review found association between WML severity and freezing of gait, less significant to responsiveness to dopaminergic treatment and postural instability; no negative impact on tremor and falls was observed. The impact of WML on bradykinesia and rigidity was inconsistent. Comorbid WML is associated with worsening axial motor performance, probably independently from the degree of nigrostriatal dopaminergic denervation in PD. Reducing the vascular risk factors that cause WML may be helpful in preventing the development of axial symptoms and ultimately in improving the quality of life of patients with PD. Given the lack of systematic studies, additional research in this field is needed.

1st Department of Neurology Center of Neuroscience and Movement Disorders Centre Central European Institute of Technology St Anne's University Hospital School of Medicine Masaryk University Pekařská 664 53 656 91 Brno Czech Republic

Department of Neurology Faculty Hospital Nitra Špitálska 6 949 01 Nitra Slovak Republic

Parkinson's Disease and Movement Disorders Unit IRCCS Fondazione Ospedale San Camillo Venice Italy

See more in PubMed

Mov Disord. 2006 Jan;21(1):124-5 PubMed

Neuroepidemiology. 1994;13(3):108-12 PubMed

Stroke. 2002 Jan;33(1):21-5 PubMed

J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 PubMed

Can J Neurol Sci. 2007 Feb;34(1):56-61 PubMed

Mov Disord. 2002 Jul;17(4):772-4 PubMed

Brain. 2013 Aug;136(Pt 8):2405-18 PubMed

Arch Neurol. 1995 Dec;52(12 ):1183-90 PubMed

Stroke. 2014 May;45(5):1531-8 PubMed

Ann Neurol. 1997 Jan;41(1):58-64 PubMed

Stroke. 1992 Jun;23(6):839-42 PubMed

Parkinsonism Relat Disord. 2015 Jul;21(7):692-7 PubMed

Arch Neurol. 1990 Feb;47(2):129-32 PubMed

Brain. 2011 Jan;134(Pt 1):73-83 PubMed

Nat Rev Neurol. 2015 Jun;11(6):319-26 PubMed

Lancet Neurol. 2011 Aug;10(8):734-44 PubMed

Mov Disord. 2005 Nov;20(11):1476-80 PubMed

Neurology. 2008 Mar 18;70(12):935-42 PubMed

Ann Neurol. 1990 Nov;28(5):597-613 PubMed

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):126-35 PubMed

AJR Am J Roentgenol. 1987 Aug;149(2):351-6 PubMed

Cerebrovasc Dis. 2008;25(3):247-53 PubMed

Eur J Neurol. 2012 Aug;19(8):1100-7 PubMed

Brain. 2011 Aug;134(Pt 8):2358-65 PubMed

AJNR Am J Neuroradiol. 1986 Jul-Aug;7(4):567-70 PubMed

Adv Exp Med Biol. 1984;180:545-54 PubMed

Nat Rev Neurosci. 2008 Nov;9(11):856-69 PubMed

J Neurol Sci. 2006 Oct 25;248(1-2):185-91 PubMed

Adv Neurol. 1996;69:293-303 PubMed

Neuroimage. 2009 Oct 1;47(4):2083-9 PubMed

Neurologia. 2014 May;29(4):218-23 PubMed

Parkinsonism Relat Disord. 2009 Jan;15(1):24-9 PubMed

Neuroimage. 2009 May 1;45(4):1151-61 PubMed

Clin Neurol Neurosurg. 1980;82(3):177-85 PubMed

Circulation. 2008 Feb 12;117(6):743-53 PubMed

Neurol Neurochir Pol. 2006 Jul-Aug;40(4):276-83 PubMed

Brain. 1999 Jul;122 ( Pt 7):1349-55 PubMed

Mov Disord. 1990;5(3):203-13 PubMed

Stroke. 2001 Jun;32(6):1318-22 PubMed

Parkinsonism Relat Disord. 2011 Sep;17(8):599-605 PubMed

Acta Neuropathol. 2003 May;105(5):415-9 PubMed

Rev Neurol (Paris). 1998 May;154(4):291-302 PubMed

J Appl Physiol (1985). 1987 Feb;62(2):791-7 PubMed

Stroke. 1990 Oct;21(10):1395-9 PubMed

Brain. 2011 Jan;134(Pt 1):59-72 PubMed

Mov Disord. 2012 Aug;27(9):1169-72 PubMed

Neuroimage. 2008 Jan 15;39(2):786-92 PubMed

J Aging Res. 2011;2011:391783 PubMed

Neurology. 2009 Nov 17;73(20):1670-6 PubMed

Mov Disord. 1997 Nov;12(6):1086-90 PubMed

Stroke. 2013 Apr;44(4):1147-9 PubMed

Neurol Clin. 1992 May;10(2):451-69 PubMed

JAMA. 2002 Jul 3;288(1):67-74 PubMed

Arch Neurol. 2010 Nov;67(11):1379-85 PubMed

Mov Disord. 2006 Nov;21(11):1990-4 PubMed

Mov Disord. 2006 Dec;21(12):2042-51 PubMed

Mov Disord. 2008 Aug 15;23 (11):1580-7 PubMed

Stroke. 1986 Nov-Dec;17(6):1084-9 PubMed

Neurology. 2014 Apr 29;82(17 ):1514-20 PubMed

Arch Neurol. 1999 Jan;56(1):98-102 PubMed

Stroke. 2011 Jul;42(7):2086-90 PubMed

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):227-33 PubMed

Parkinsonism Relat Disord. 2010 Jan;16(1):31-5 PubMed

J Neuropathol Exp Neurol. 2010 May;69(5):442-8 PubMed

Age Ageing. 2006 Sep;35 Suppl 2:ii7-ii11 PubMed

Arch Gerontol Geriatr. 2009 Sep-Oct;49(2):255-9 PubMed

Handb Clin Neurol. 2007;84:417-25 PubMed

J Neurol Sci. 1993 Jan;114(1):7-12 PubMed

Acta Neurol Scand. 2011 Jan;123(1):41-7 PubMed

J Gerontol A Biol Sci Med Sci. 2004 Aug;59(8):818-26 PubMed

J Neurol. 2005 Sep;252(9):1045-9 PubMed

Stroke. 2003 Feb;34(2):441-5 PubMed

Neurology. 2001 Nov;57(10 Suppl 3):S11-26 PubMed

Parkinsonism Relat Disord. 2012 Jul;18(6):775-80 PubMed

PLoS One. 2013;8(1):e55193 PubMed

Yonsei Med J. 1998 Feb;39(1):50-5 PubMed

Mov Disord. 2010 Jan 15;25(1):50-6 PubMed

Mov Disord. 2013 Sep 15;28(11):1560-5 PubMed

Arch Neurol. 1995 Feb;52(2):191-4 PubMed

Ann Neurol. 2000 Feb;47(2):145-51 PubMed

Acta Neurol Scand. 2002 May;105(5):414-5 PubMed

J Neurol Sci. 2007 Jun 15;257(1-2):97-104 PubMed

Mov Disord. 2006 Feb;21(2):223-9 PubMed

Neurol Neurochir Pol. 2008 Nov-Dec;42(6):505-12 PubMed

Parkinsonism Relat Disord. 2013 Aug;19(8):761-3 PubMed

Neurology. 1994 Oct;44(10):1865-8 PubMed

Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13(4):226-31 PubMed

Brain Pathol. 2013 Mar;23(2):154-64 PubMed

Neurology. 1990 Oct;40(10):1529-34 PubMed

J Neurol. 2004 May;251(5):513-24 PubMed

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S166-70 PubMed

Parkinsonism Relat Disord. 2013 Jul;19(7):680-3 PubMed

Neurodegener Dis. 2013;12(1):1-12 PubMed

Neurobiol Aging. 2003 Mar-Apr;24(2):197-211 PubMed

Parkinsonism Relat Disord. 2009 Jan;15(1):64-7 PubMed

J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):545-7 PubMed

Cardiovasc Res. 1996 Oct;32(4):632-43 PubMed

Stroke. 2006 Mar;37(3):836-40 PubMed

Mov Disord. 2015 Jun;30(7):886-94 PubMed

Parkinsonism Relat Disord. 2015 Jul;21(7):704-8 PubMed

Mov Disord. 2003 Oct;18 Suppl 7:S43-51 PubMed

Quantitative Analysis of Relationship Between Hypokinetic Dysarthria and the Freezing of Gait in Parkinson's Disease

White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy